Skip to content
DefDex

Federal award

GEN-PROBE INCORPORATED

W81K0210P0179

Contract

Obligated and Ceiling

Obligated (net)
$2,628,290.50
Ceiling (potential value, not spending)
$2,628,290.50
Current value
$2,628,290.50
Gross positive obligations
$3,259,012.50

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
GEN-PROBE INCORPORATED · QNXWLAJDL4J3
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
GRIFOLS SA · G9PNB5K6E1U8
Awarding agency
Department of War · sub-agency 2100 · office W81K02
Funding agency
Department of War · sub-agency 2100
Product or service (PSC)
6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Industry (NAICS)
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
PIID
W81K0210P0179
Award type code
B
Actions
24 · Sep 21, 2010 to Sep 22, 2018
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History24

Award actions
DateFYModAction typeObligationCompany in company totals
Sep 22, 2018FY2018P00023K−$441,206.00
—
Feb 25, 2015FY2015P00022B$0.00
—
Oct 16, 2014FY2015P00021C$652,522.50
—
Jul 30, 2014FY2014P00020G−$12,000.00
—
Nov 21, 2013FY2014P00019C$652,522.50
—
Oct 7, 2013FY2014P00018M$0.00
—
Sep 11, 2013FY2013P00017B$0.00
—
Jun 27, 2013FY2013P00016M$0.00
—
Apr 15, 2013FY2013P00015G$0.00
—
Mar 28, 2013FY2013P00014B$0.00
—
Oct 23, 2012FY2013P00013C$651,322.50
—
Oct 10, 2012FY2013P00012B$0.00
—
Sep 19, 2012FY2012P00011C−$61,190.00
—
Jun 8, 2012FY2012P00010G$0.00
—
Jun 7, 2012FY2012P00009B−$46,750.00
—
May 15, 2012FY2012P00008B$0.00
—
Jan 12, 2012FY2012P00007C−$2,565.00
—
Nov 17, 2011FY2012P00006C$651,322.50
—
Sep 16, 2011FY2011P00005C−$37,011.00
—
Sep 12, 2011FY2011P00004G$0.00
—
May 18, 2011FY2011P00003C−$30,000.00
—
Oct 26, 2010FY2011P00002M$0.00
—
Oct 17, 2010FY2011P00001M$651,322.50
—
Sep 21, 2010FY20100—$0.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.